159 related articles for article (PubMed ID: 15807267)
1. [Expression with TGFbeta1 in the patients with ulcerative colitis].
Wang YF; Wei B; Ouyang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):204-6. PubMed ID: 15807267
[TBL] [Abstract][Full Text] [Related]
2. Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta1.
Wiercińska-Drapało A; Flisiak R; Prokopowicz D
Cytokine; 2001 Jun; 14(6):343-6. PubMed ID: 11497495
[TBL] [Abstract][Full Text] [Related]
3. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
Tsukada Y; Nakamura T; Iimura M; Iizuka BE; Hayashi N
Am J Gastroenterol; 2002 Nov; 97(11):2820-8. PubMed ID: 12425554
[TBL] [Abstract][Full Text] [Related]
4. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
Li MR; Jiang K; Zhang QY
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):957-60. PubMed ID: 18756966
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta1 and prostaglandin E2 concentrations are associated with bone formation markers in ulcerative colitis patients.
Wiercinska-Drapalo A; Jaroszewicz J; Tarasow E; Flisiak R; Prokopowicz D
Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):160-8. PubMed ID: 16303613
[TBL] [Abstract][Full Text] [Related]
6. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
Yantiss RK; Das KM; Farraye FA; Odze RD
Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
[TBL] [Abstract][Full Text] [Related]
7. Decreased Toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients.
Stanislawowski M; Wierzbicki PM; Golab A; Adrych K; Kartanowicz D; Wypych J; Godlewski J; Smoczynski M; Kmiec Z
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():71-5. PubMed ID: 20083854
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC).
Gionchetti P; Campieri M; Belluzzi A; Tampieri M; Bertinelli E; Brignola C; Ferretti M; Boni P; Iannone P; Miglioli M
Agents Actions; 1992; Spec No():C50-2. PubMed ID: 1442335
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx.
Kojc N; Zidar N; Vodopivec B; Gale N
Hum Pathol; 2005 Jan; 36(1):16-21. PubMed ID: 15712177
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 and its receptors in patients with ulcerative colitis.
Stadnicki A; Machnik G; Klimacka-Nawrot E; Wolanska-Karut A; Labuzek K
Int Immunopharmacol; 2009 Jun; 9(6):761-6. PubMed ID: 19285572
[TBL] [Abstract][Full Text] [Related]
11. [Effect of Kuijieling decoction on proteins expression of IKK-alpha in colonic mucosa of ulcerative colitis model rats].
Du Q; Li H; Wang RJ; Li YW; Wu YL; Wang JH
Zhong Yao Cai; 2008 Jul; 31(7):1016-8. PubMed ID: 18973019
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: correlation with disease activity.
Inoue S; Matsumoto T; Iida M; Mizuno M; Kuroki F; Hoshika K; Shimizu M
Am J Gastroenterol; 1999 Sep; 94(9):2441-6. PubMed ID: 10484006
[TBL] [Abstract][Full Text] [Related]
13. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal/permeability-increasing protein in colonic mucosa in ulcerative colitis.
Haapamäki MM; Häggblom JO; Grönroos JM; Pekkala E; Alanen K; Nevalainen TJ
Hepatogastroenterology; 1999; 46(28):2273-7. PubMed ID: 10521980
[TBL] [Abstract][Full Text] [Related]
15. [Expression of transforming growth factor-beta1 in cervical squamous carcinoma cell and stroma].
Li XG; Zou XH; Zhang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):44-6. PubMed ID: 16137003
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of signal transducer and activator of transcription-3 is associated with aggravation of ulcerative colitis.
Li F; Zou Y; Li X
Surgeon; 2010 Oct; 8(5):262-6. PubMed ID: 20709283
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
18. [The expression of toll-like receptor4 and NF-kappaB in ulcerative colitis].
Yu ZH; Chen LD; Wang ZQ; Xu N
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):650-2. PubMed ID: 20862798
[TBL] [Abstract][Full Text] [Related]
19. Study on the correlations among disease activity index and salivary transforming growth factor-beta 1 and nitric oxide in ulcerative colitis patients.
Rezaie A; Khalaj S; Shabihkhani M; Nikfar S; Zamani MJ; Mohammadirad A; Daryani NE; Abdollahi M
Ann N Y Acad Sci; 2007 Jan; 1095():305-14. PubMed ID: 17404043
[TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin inhibits cytokine-induced nitric oxide production in human colonic epithelium.
Kolios G; Manousou P; Bourikas L; Notas G; Tsagarakis N; Mouzas I; Kouroumalis E
Eur J Clin Invest; 2006 Oct; 36(10):720-9. PubMed ID: 16968468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
